H. Lundbeck AS (LTS:0ABR) Cyclically Adjusted Revenue per Share: kr60.87 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0ABR H. Lundbeck AS LTS:0ABR
77 GF Score
Price kr36.00
GF Value kr38.17
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is H. Lundbeck AS Cyclically Adjusted Revenue per Share?

H. Lundbeck AS LTS:0ABR 77 Cyclically Adjusted Revenue per Share is kr60.87 as of Mar. 2026. GuruFocus rates LTS:0ABR with a GF Score™ of 77/100 and a GF Value™ of kr38.17 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

H. Lundbeck AS's adjusted revenue per share for the three months ended in Mar. 2026 was kr7.180. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr60.87 for the trailing ten years ended in Mar. 2026.

During the past 12 months, H. Lundbeck AS's average Cyclically Adjusted Revenue Growth Rate was -8.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of H. Lundbeck AS was 1.70% per year. The lowest was -7.30% per year. And the median was -2.45% per year.

As of today (2026-07-20), H. Lundbeck AS's current stock price is kr36.00. H. Lundbeck AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr60.87. H. Lundbeck AS's Cyclically Adjusted PS Ratio of today is 0.59.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of H. Lundbeck AS was 0.62. The lowest was 0.27. And the median was 0.44.


H. Lundbeck AS  (LTS:0ABR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

H. Lundbeck AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=36.00/60.87
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of H. Lundbeck AS was 0.62. The lowest was 0.27. And the median was 0.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


H. Lundbeck AS Cyclically Adjusted Revenue per Share Related Terms


H. Lundbeck AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Cyclically Adjusted Revenue per Share Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 80.52 73.82 69.14 63.57

H. Lundbeck AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.28 67.01 67.35 63.57 60.87

LTS:0ABR vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Cyclically Adjusted PS Ratio falls into.


LTS:0ABR
77GF Score
H. Lundbeck AS LTS:0ABR
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, H. Lundbeck AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.18/121.6800*121.6800
=7.180

Current CPI (Mar. 2026) = 121.6800.

H. Lundbeck AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 19.002 100.600 22.984
201609 20.000 100.200 24.287
201612 21.420 100.300 25.986
201703 21.343 101.200 25.662
201706 21.653 101.200 26.035
201709 21.915 101.800 26.195
201712 22.393 101.300 26.898
201803 23.075 101.700 27.608
201806 23.669 102.300 28.153
201809 23.305 102.400 27.693
201812 19.885 102.100 23.698
201903 21.309 102.900 25.198
201906 21.369 102.900 25.269
201909 20.810 102.900 24.608
201912 23.863 102.900 28.218
202003 22.958 103.300 27.043
202006 21.982 103.200 25.918
202009 22.461 103.500 26.406
202012 21.501 103.400 25.302
202103 21.505 104.300 25.088
202106 3.987 105.000 4.620
202109 4.040 105.800 4.646
202112 4.080 106.600 4.657
202203 4.401 109.900 4.873
202206 4.519 113.600 4.840
202209 4.733 116.400 4.948
202212 4.714 115.900 4.949
202303 5.080 117.300 5.270
202306 4.938 116.400 5.162
202309 4.981 117.400 5.163
202312 5.018 116.700 5.232
202403 5.330 118.400 5.478
202406 5.524 118.500 5.672
202409 5.744 118.900 5.878
202412 5.590 118.900 5.721
202503 6.286 120.200 6.363
202506 6.048 120.700 6.097
202509 6.330 121.600 6.334
202512 6.141 121.200 6.165
202603 7.180 121.680 7.180

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr60.87 mean?
H. Lundbeck AS (LTS:0ABR) has a Cyclically Adjusted Revenue per Share of kr60.87 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on H. Lundbeck AS and its competitors.
Is H. Lundbeck AS's Cyclically Adjusted Revenue per Share too high?
H. Lundbeck AS's current Cyclically Adjusted Revenue per Share is kr60.87. Overall, H. Lundbeck AS has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
H. Lundbeck AS's Cyclically Adjusted Revenue per Share of kr60.87 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on H. Lundbeck AS and its competitors. H. Lundbeck AS's current Cyclically Adjusted Revenue per Share is kr60.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (LTS:0ABR) is currently considered Fairly Valued. The stock's GF Value™ is kr38.17, compared to a current price of kr36.00 — trading 5.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr60.87. H. Lundbeck AS's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For H. Lundbeck AS (LTS:0ABR), the current Cyclically Adjusted Revenue per Share is kr60.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H. Lundbeck AS (LTS:0ABR) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of kr36.00 is trading 5.7% below its estimated GF Value™ of kr38.17. GuruFocus considers H. Lundbeck AS to be Fairly Valued.

Key valuation signals for LTS:0ABR:

  • Cyclically Adjusted Revenue per Share: kr60.87
  • GF Value™: kr38.17 vs. price of kr36.00 (5.7% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the LTS:0ABR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
77GF Score

Get the complete analysis for LTS:0ABR

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr36.00
Price
kr38.17
GF Value